<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>Mike Apted &#8211; Noise</title>
	<atom:link href="https://noise.getoto.net/author/mike-apted/feed/" rel="self" type="application/rss+xml" />
	<link>https://noise.getoto.net</link>
	<description>The collective thoughts of the interwebz</description>
	<lastBuildDate>Thu, 10 Jun 2021 02:59:41 +0000</lastBuildDate>
	<language>en-US</language>
	<sy:updatePeriod>
	hourly	</sy:updatePeriod>
	<sy:updateFrequency>
	1	</sy:updateFrequency>
	<generator>https://wordpress.org/?v=6.8.2</generator>
	<item>
		<title>Choosing a CI/CD approach: AWS Services with BigHat Biosciences</title>
		<link>https://noise.getoto.net/2021/06/10/choosing-a-ci-cd-approach-aws-services-with-bighat-biosciences/</link>
		
		<dc:creator><![CDATA[Mike Apted]]></dc:creator>
		<pubDate>Thu, 10 Jun 2021 02:59:41 +0000</pubDate>
				<category><![CDATA[Amazon CloudWatch]]></category>
		<category><![CDATA[Amazon ECR]]></category>
		<category><![CDATA[AWS CodeBuild]]></category>
		<category><![CDATA[AWS CodePipeline]]></category>
		<category><![CDATA[AWS X-Ray]]></category>
		<category><![CDATA[BigHat]]></category>
		<category><![CDATA[CI/CD]]></category>
		<category><![CDATA[cloud]]></category>
		<category><![CDATA[CloudFormation]]></category>
		<category><![CDATA[Customer Solutions]]></category>
		<guid isPermaLink="false">http://noise.getoto.net/?guid=ddea6514bd193732cfb8a4cd0cb48d4c</guid>

					<description><![CDATA[Founded in 2019, BigHat Biosciences’ mission is to improve human health by reimagining antibody discovery and engineering to create better antibodies faster. Their integrated computational + experimental approach speeds up antibody design and discovery by combining high-speed molecular characterization with machine learning technologies to guide the search for better antibodies. They apply these design capabilities […]]]></description>
		
		
		<enclosure url="" length="0" type="" />

			</item>
	</channel>
</rss>

<!--
Performance optimized by W3 Total Cache. Learn more: https://www.boldgrid.com/w3-total-cache/

Object Caching 42/44 objects using Memcached
Page Caching using Disk: Enhanced 
Lazy Loading (feed)
Database Caching using Memcached

Served from: noise.getoto.net @ 2026-02-06 15:53:32 by W3 Total Cache
-->